Penumbra, Inc. (NYSE:PEN) EVP Sells $146,694.00 in Stock

Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts sold 600 shares of the business’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $244.49, for a total value of $146,694.00. Following the transaction, the executive vice president now owns 63,444 shares in the company, valued at $15,511,423.56. This represents a 0.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Johanna Roberts also recently made the following trade(s):

• On Monday, November 18th, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $239.74, for a total value of $143,844.00.
• On Tuesday, October 1st, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $190.76, for a total value of $114,456.00.

Penumbra Stock Up 1.6 %

NYSE:PEN opened at $249.12 on Thursday. The stock’s fifty day moving average price is $220.08 and its two-hundred day moving average price is $199.38. Penumbra, Inc. has a 52-week low of $148.00 and a 52-week high of $277.34. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.25 and a current ratio of 5.82. The company has a market cap of $9.56 billion, a price-to-earnings ratio of 289.67, a P/E/G ratio of 2.46 and a beta of 0.51.

Penumbra (NYSE:PEN) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.16. Penumbra had a return on equity of 8.99% and a net margin of 2.97%. The firm had revenue of $301.04 million for the quarter, compared to the consensus estimate of $297.36 million. During the same quarter in the prior year, the business earned $0.67 EPS. The business’s revenue for the quarter was up 11.1% compared to the same quarter last year. On average, analysts anticipate that Penumbra, Inc. will post 2.81 EPS for the current year.

Penumbra declared that its board has initiated a stock repurchase program on Tuesday, August 13th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the company to buy up to 2.6% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s board believes its shares are undervalued.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Truist Financial upped their price objective on Penumbra from $200.00 to $235.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Leerink Partnrs upgraded Penumbra to a “strong-buy” rating in a research note on Tuesday, September 3rd. Leerink Partners assumed coverage on Penumbra in a research note on Tuesday, September 3rd. They issued an “outperform” rating and a $263.00 price objective on the stock. Royal Bank of Canada upped their price objective on Penumbra from $205.00 to $222.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Finally, Robert W. Baird upped their price objective on Penumbra from $244.00 to $248.00 and gave the company an “outperform” rating in a research note on Thursday, October 31st. Five equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $230.92.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of PEN. Advisors Asset Management Inc. raised its position in shares of Penumbra by 11.5% during the 3rd quarter. Advisors Asset Management Inc. now owns 416 shares of the company’s stock valued at $81,000 after acquiring an additional 43 shares during the last quarter. ProShare Advisors LLC increased its holdings in Penumbra by 2.9% during the 2nd quarter. ProShare Advisors LLC now owns 2,171 shares of the company’s stock worth $391,000 after purchasing an additional 62 shares in the last quarter. Legacy Wealth Asset Management LLC increased its holdings in Penumbra by 3.9% during the 3rd quarter. Legacy Wealth Asset Management LLC now owns 1,731 shares of the company’s stock worth $336,000 after purchasing an additional 65 shares in the last quarter. Creative Planning increased its holdings in Penumbra by 4.7% during the 3rd quarter. Creative Planning now owns 1,574 shares of the company’s stock worth $306,000 after purchasing an additional 71 shares in the last quarter. Finally, Arcadia Investment Management Corp MI increased its holdings in Penumbra by 7.9% during the 2nd quarter. Arcadia Investment Management Corp MI now owns 1,006 shares of the company’s stock worth $181,000 after purchasing an additional 74 shares in the last quarter. Institutional investors and hedge funds own 88.88% of the company’s stock.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.